Back to Investors
1C

11.2 Capital

Venture Capital

11.2 Capital invests in founders addressing global challenges, focusing on emerging technologies in data-driven healthcare, AI, and infrastructure software.

Portfolio

1

companies


Portfolio companies

uMed

uMed

Research technology platform automating clinical studies and patient registries for healthcare providers.


Recent investments

Seed
£3.7M

The seed follow-on round was backed by a consortium including AlbionVC, Delin Ventures, and Playfair Capital.

"Our technology can support healthcare providers in finding appropriate patients to participate in medical research including large scale patient registries which usually demands laborious, manual processes on top of their already complex and heavy workloads."
— Matt Wilson, Founder and CEO